The future of anticoagulation management in atrial fibrillation in Europe
Jun 1, 2015
An assessment of today's challenges with recommendations for the future: Annexes
|PDF file||1 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
As heart arrhythmia atrial fibrillation (AF) is becoming more prevalent, we explored current and future landscapes for AF-related stroke prevention. Our recommendations target awareness, education and maintaining engagement across health services. This annexes document contains study methods and detailed results.
The research described in this report was conducted by RAND Europe.
This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.